Biosimilar Roadblock Removals Seem Tailor-Made for Trump/Democrats Agreement: Development of New Biosimilar Drugs and Marketing of Few Approved Drugs Stymied
{{output}}
The United States is lagging behind Europe in biosimilar use, and missing out on a wider range of medication options and huge savings in drug expenditures. What's causing the holdup? ... ...
